Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88814096 | 8881409 | 6 | F | 20111017 | 20160826 | 20121101 | 20160901 | EXP | US-ASTRAZENECA-2012SE81733 | ASTRAZENECA | 18519.00 | DY | F | Y | 117.90000 | KG | 20160901 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88814096 | 8881409 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | 40 | MG | CAPSULE | QD | |||||||
| 88814096 | 8881409 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | 40 | MG | CAPSULE | QD | |||||||
| 88814096 | 8881409 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | ESOMEPRAZOLE MAGNESIUM 40MG DAILY | 21153 | ||||||||||
| 88814096 | 8881409 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | ESOMEPRAZOLE MAGNESIUM 40MG DAILY | 21153 | ||||||||||
| 88814096 | 8881409 | 5 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 23.2MG DAILY | U | U | 0 | ||||||||
| 88814096 | 8881409 | 6 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG TWO PUFFS TWICE A DAY | U | U | 0 | ||||||||
| 88814096 | 8881409 | 7 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG TWO PUFFS TWICE A DAY | U | U | 0 | ||||||||
| 88814096 | 8881409 | 8 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG TWO PUFFS TWICE A DAY | U | U | 0 | ||||||||
| 88814096 | 8881409 | 9 | C | CELEBREX | CELECOXIB | 1 | 0 | 200 | MG | CAPSULE | QD | ||||||||
| 88814096 | 8881409 | 10 | C | CELEBREX | CELECOXIB | 1 | 0 | 200 | MG | CAPSULE | QD | ||||||||
| 88814096 | 8881409 | 11 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | 60 | MG | CAPSULE | QD | ||||||||
| 88814096 | 8881409 | 12 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | 1-2 QID | 0 | |||||||||||
| 88814096 | 8881409 | 13 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | AS NEEDED | 0 | |||||||||||
| 88814096 | 8881409 | 14 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | 18/103 MCG, 2 QID | 0 | |||||||||||
| 88814096 | 8881409 | 15 | C | BLACK COHESH | 2 | 0 | |||||||||||||
| 88814096 | 8881409 | 16 | C | ZEGRID | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88814096 | 8881409 | 1 | Gastrooesophageal reflux disease |
| 88814096 | 8881409 | 2 | Gastrooesophageal reflux disease |
| 88814096 | 8881409 | 3 | Gastrooesophageal reflux disease |
| 88814096 | 8881409 | 4 | Gastrooesophageal reflux disease |
| 88814096 | 8881409 | 5 | Gastrooesophageal reflux disease |
| 88814096 | 8881409 | 6 | Pneumonia |
| 88814096 | 8881409 | 7 | Bronchitis |
| 88814096 | 8881409 | 8 | Asthma |
| 88814096 | 8881409 | 9 | Arthritis |
| 88814096 | 8881409 | 10 | Arthritis |
| 88814096 | 8881409 | 11 | Depression |
| 88814096 | 8881409 | 15 | Hot flush |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 88814096 | 8881409 | HO |
| 88814096 | 8881409 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88814096 | 8881409 | Arthralgia | |
| 88814096 | 8881409 | Bronchitis | |
| 88814096 | 8881409 | Decreased appetite | |
| 88814096 | 8881409 | Depression | |
| 88814096 | 8881409 | Dyspepsia | |
| 88814096 | 8881409 | Dysphagia | |
| 88814096 | 8881409 | Gastrooesophageal reflux disease | |
| 88814096 | 8881409 | Headache | |
| 88814096 | 8881409 | Heart rate increased | |
| 88814096 | 8881409 | Intentional product misuse | |
| 88814096 | 8881409 | Intervertebral disc degeneration | |
| 88814096 | 8881409 | Muscle spasms | |
| 88814096 | 8881409 | Nasopharyngitis | |
| 88814096 | 8881409 | Neck pain | |
| 88814096 | 8881409 | Nervousness | |
| 88814096 | 8881409 | Osteoarthritis | |
| 88814096 | 8881409 | Pneumonia | |
| 88814096 | 8881409 | Spinal pain | |
| 88814096 | 8881409 | Vertebral lesion | |
| 88814096 | 8881409 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 88814096 | 8881409 | 1 | 2007 | 0 | ||
| 88814096 | 8881409 | 2 | 2007 | 0 | ||
| 88814096 | 8881409 | 3 | 2015 | 0 | ||
| 88814096 | 8881409 | 4 | 2015 | 0 | ||
| 88814096 | 8881409 | 5 | 2016 | 0 | ||
| 88814096 | 8881409 | 6 | 2013 | 0 | ||
| 88814096 | 8881409 | 7 | 2013 | 0 | ||
| 88814096 | 8881409 | 8 | 2013 | 0 | ||
| 88814096 | 8881409 | 9 | 20111221 | 0 | ||
| 88814096 | 8881409 | 10 | 2006 | 0 | ||
| 88814096 | 8881409 | 11 | 2009 | 0 | ||
| 88814096 | 8881409 | 12 | 20111019 | 0 | ||
| 88814096 | 8881409 | 13 | 20111019 | 0 | ||
| 88814096 | 8881409 | 14 | 20111017 | 0 |